Department of Medicine, Division of Hematology, London Health Sciences Centre, London, Ontario, Canada.
Thromb J. 2010 May 18;8:10. doi: 10.1186/1477-9560-8-10.
Protein C (PC) and protein S (PS) determination is part of the thrombophilia investigation in patients with idiopathic venous thromboembolism (VTE). Based on scarce evidence it is a common notion that PC and PS levels decrease during the acute phase of VTE, necessitating delay of testing and temporary transition from warfarin to low molecular weight heparin. We have previously demonstrated that an abnormal PC or PS result determined within 24 hours of VTE diagnosis and before the initiation of warfarin needs to be repeated for confirmation >/=3 months after starting treatment and >/=14 days after stopping anticoagulation therapy. In the current study, we sought to show that normal PC and PS values determined during the acute phase of VTE are not false negatives.
99 patients with acute idiopathic VTE who had normal PC and PS determination within the first 24 hours of presentation and who subsequently had their oral anticoagulation discontinued after six months of therapy. PC and PS determinations were repeated >/=6 months after starting treatment and >/= 14 days after stopping warfarin. Proportions of patients who tested abnormal on the second test were calculated and 95% confidence intervals obtained using the Wilson's score method. Data from a previously published study on patients with abnormal initial tests was included for comparison.
None of the 99 patients who had normal PC and PS initially had an abnormal result on repeated testing (0%; 95% CI 0 - 3.7%). Data from the previous study showed that, among patients who initially had abnormal results, 40% (95%CI 35.4-84.8%) were confirmed to have low PC and 63.6% (95%CI 16.8-68.7%) low PS on repeated testing. The difference between proportions was statistically significant (chi2 p-value < 0.001).
Our results suggest that PC and PS can be determined during the acute phase of VTE and whereas abnormal results need to be confirmed with repeat testing at a later date, a normal result effectively rules out deficiency with only one test.
蛋白 C(PC)和蛋白 S(PS)的测定是对特发性静脉血栓栓塞症(VTE)患者进行血栓形成倾向研究的一部分。基于有限的证据,人们普遍认为 PC 和 PS 水平在 VTE 的急性期会降低,这需要延迟检测,并临时将华法林转换为低分子量肝素。我们之前已经证明,在 VTE 诊断后 24 小时内和开始华法林治疗之前确定的异常 PC 或 PS 结果需要在开始治疗后 3 个月和停止抗凝治疗后 14 天以上进行重复以确认。在当前的研究中,我们试图证明在 VTE 的急性期确定的正常 PC 和 PS 值不是假阴性。
99 例急性特发性 VTE 患者,在就诊的前 24 小时内 PC 和 PS 测定正常,随后在 6 个月的治疗后停止口服抗凝治疗。在开始治疗后 6 个月以上和停止华法林后 14 天以上,重复进行 PC 和 PS 测定。计算第二次检测异常的患者比例,并使用威尔逊分数法获得 95%置信区间。纳入先前发表的关于初始检测异常患者的研究数据进行比较。
在最初 PC 和 PS 正常的 99 例患者中,无一人在重复检测时结果异常(0%;95%CI 0-3.7%)。先前研究的数据显示,在最初检测结果异常的患者中,40%(95%CI 35.4-84.8%)被确认为 PC 降低,63.6%(95%CI 16.8-68.7%)为 PS 降低。两组比例差异具有统计学意义(卡方检验 p 值<0.001)。
我们的结果表明,PC 和 PS 可以在 VTE 的急性期进行测定,虽然异常结果需要在以后的日期进行重复检测以确认,但一次正常的检测结果实际上可以排除缺陷。